AIM: WYN

Wynnstay Group plc

("Wynnstay" or the "Company")

Agricultural supplies and services group

Director and PDMR dealing, Award of Options, and Total Voting Rights

Wynnstay, the agricultural supplies group, announces director share dealings and the exercise of options by a person discharging managerial responsibilities ("PDMR"), as well as details of the award of options and total voting rights.

·    Director / PDMR share purchase and exercise of options

Alk Brand, Chief Executive Officer, purchased 2,000 ordinary shares of 25p each in the Company ("Ordinary Shares") on 11 February 2025. Also on 11 February 2025, Claire Williams, Company Secretary, exercised 1,221 options under the established Wynnstay Performance Share Plan (the "Plan") over Ordinary Shares in relation to the 2020 Plan. The Ordinary Shares were issued from the ESOP Trust for nil consideration.  Further details are below.

·    Award of Options under the Company's 2025 Performance Share Plan

An award of options ("Options") over Ordinary Shares approved under the terms of the established Wynnstay Performance Share Plan ("PSP") has been made. The Options offer the recipients the entitlement to acquire a maximum number of Ordinary Shares ("Award Shares") on or after 31 October 2027 at nil cost, subject to the Company achieving the following minimum reported performance criteria:

1.    50% of Award Shares will vest if the Company's earnings per share ("EPS") equals or exceeds a minimum of 39 pence per share. 

2.    A maximum of 100% of Award Shares will vest if the Company's EPS equals or exceeds 47 pence per share.  A sliding scale will operate between the minimum and maximum EPS.

The Remuneration Committee has responsibility for determining the award of Options and the performance targets under the Plan.

The total number of 2025 Award Shares over which the Options have been granted amounts to 307,460, and included in this grant were the Options awarded to the following Directors and persons discharging managerial responsibilities:

·    Award of Options under the Company's 2023 Performance Share Plan

In addition, the Company announces the award of 6,981 options over Ordinary Shares approved under the terms of PSP to Claire Williams under the same terms as those awarded to other Company Executives under the 2023 PSP awards as announced on 10 February 2023, at which time Claire Williams was on medical leave.

·    Director / PDMR Shareholdings

Following the share purchase, exercise of options and grant of awards as outlined above, the director/PDMR beneficial holdings and options over the Company's issued share capital are shown below. 

*PSP awards granted to Gareth Davies whilst Chief Executive Officer

** PSP award granted to Claire Williams on 11 February 2025 under the same terms as those awarded to other Company Executives on 10 February 2023, at which time Claire Williams was on medical leave.

·    Total Voting Rights

For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of Ordinary Shares in issue is 23,127,360 with each share carrying the right to one vote. There are no shares held in treasury, therefore the total number of voting rights in the Company at Admission is 23,127,360.

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules.

The notifications below, made in accordance with Article 19 of the UK Market Abuse Regulation, provide further detail.

For further details please contact: